My opinion (for what it's worth) is that we now have a floor for the price of Atrum. Clearly, Russell & Gino were responsible for the bulk of last week's selling and it has prompted a "group" of investors to draw a line in the sand and tempt them to sell down to 30c. I suspect a bit of cat and mouse is probably taking place behind the scenes as well.
I am unsure how much of Russell & Gino's stock is obligated to their lender, but I've heard it is in the region of 30m shares. That leaves them with a total Atrum holding around 10-12m shares.
Assuming Russell & Gino's lender is happy to retain exposure to Atrum, then this effectively eradicates the overhang which has been plaguing the stock since June last year (among other things!!).
With the Bulk Sample Permit just around the corner, quickly followed by the sale of an equity stake in GHN, I think the time has just about arrived to pin the ears back and get stuck in!
- Forums
- ASX - By Stock
- ATU
- Ann: Quarterly Activities and Cash Flow Report
Ann: Quarterly Activities and Cash Flow Report, page-16
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATU (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.25M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
ATU (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online